With 2017 in the books, The Office of Prescription Drug Promotion (OPDP) continued on its multi-year trend of issuing less enforcement letters for drug promotion. At the height in 2010, OPDP issued 52 violations. In 2017, the final tally was 5. Why such a precipitous drop? The reason isn't clearly known, some have indicated that [...]The post Another low year for OPDP violations: Are we getting better or are the chains loosening? appeared first on precisioneffect.
